Download PDF
pferde spiegel 2014; 17(4): 154-158
DOI: 10.1055/s-0034-1383198
fachspiegel
Enke Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG Stuttgart · New York

Schmerz und Schmerzmanagement bei Pferden – Wo stehen wir heute?

Klaus Hopster
Further Information

Publication History

Publication Date:
16 December 2014 (online)

    Permissions and Reprints All articles of this category

In den letzten 20 bis 30 Jahren sind im Bereich der Schmerzerkennung und -therapie beim Pferd große Fortschritte zu verzeichnen. Dennoch wird der Einsatz von Analgetika in der Pferdemedizin immer noch von einem Abwägen von Nutzen, Nebenwirkungen und wirtschaftlichen Faktoren bestimmt. Trotz neuer Studien ist es weiterhin schwierig, Schmerzen und deren Ausmaß bei Pferden aufgrund ihres besonderen Verhaltens subjektiv einzuschätzen. Optimale Strategien für eine erfolgreiche Schmerztherapie basieren somit auf der Einschätzung des Schweregrads und der Pathogenese. Im Folgenden sollen verschiedene Möglichkeiten der Schmerztherapie sowohl bei akuten wie auch bei chronischen Schmerzzuständen diskutiert werden.

Literaturverzeichnis als PDF

 

  • Literatur

  • 1 Boas RA, Covino BG, Shahnarian A. Analgesic responses to i.v. lignocaine. Br J Anaesth 1982; 54 (5) 501-505
    CrossrefGoogle Scholar
  • 2 Brunson DB, Majors LJ. Comparative analgesia of xylazine, xylazine/morphine, xylazine/butorphanol, and xylazine/nalbuphine in the horse, using dental dolorimetry. Am J Vet Res 1987; 48 (7) 1087-1091
    Google Scholar
  • 3 Davis JL, Posner LP, Elce Y. Gabapentin for the treatment of neuropathic pain in a pregnant horse. J Am Vet Med Assoc 2007; 231 (5) 755-758
    CrossrefGoogle Scholar
  • 4 Delbeke FT, Vynckier L, Debackere M. The disposition of suxibuzone in the horse. J Vet Pharmacol Ther 1993; 16: 283-290
    CrossrefGoogle Scholar
  • 5 Dhanjal JK, Wilson DV, Robinson E, Tobin TT, Dirikolu L. Intravenous tramadol: effects, nociceptive properties, and pharmacokinetics in horses. Vet Anaesth Analg 2009; 36 (6) 581-590
    CrossrefGoogle Scholar
  • 6 Dönselmann im Sande P. Der Einfluss verschiedener Morphinderivate auf den thermischen nozizeptiven Schwellenwert beim Pferd. Dissertation. TiHo Hannover; 2013
    Google Scholar
  • 7 Doucet MY, Bertone AL, Hendrickson D, Hughes F, Macallister C, McClure S, Reinemeyer C, Rossier Y, Sifferman R, Vrins AA, White G, Kunkle B, Alva R, Romano D, Hanson PD. Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis. J Am Vet Med Assoc 2008; 232 (1) 91-97
    CrossrefGoogle Scholar
  • 8 Eberspächer E, Stanley SD, Rezende M, Steffey EP. Pharmacokinetics and tolerance of transdermal fentanyl administration in foals. Vet Anaesth Analg 2008; 35 (3) 249-255
    CrossrefGoogle Scholar
  • 9 Elfenbein JR, Sanchez LC, Robertson SA, Cole CA, Sams R. Effect of detomidine on visceral and somatic nociception and duodenal motility in conscious adult horses. Vet Anaesth Analg 2009; 36 (2) 162-172
    CrossrefGoogle Scholar
  • 10 Enderle AK, Levionnois OL, Kuhn M, Schatzmann U. Clinical evaluation of ketamine and lidocaine intravenous infusions to reduce isoflurane requirements in horses under general anaesthesia. Vet Anaesth Analg 2008; 35 (4) 297-305
    CrossrefGoogle Scholar
  • 11 England GC, Clarke KW. Alpha 2 adrenoceptor agonists in the horse – A review. Br Vet J 1996; 152 (6) 641-657
    CrossrefGoogle Scholar
  • 12 Fielding CL, Brumbaugh GW, Matthews NS, Peck KE, Roussel AJ. Pharmacokinetics and clinical effects of a subanesthetic continuous rate infusion of ketamine in awake horses. Am J Vet Res 2006; 67 (9) 1484-1490
    CrossrefGoogle Scholar
  • 13 Foreman JH, Bergstrom BE, Golden KS, Roark JJ, Coren DS, Foreman CR, Schumacher SA. Dose titration of the clinical efficacy of intravenously administered flunixin meglumine in a reversible model of equine foot lameness. Equine Vet J 2012; 44 (43) 17-20
    CrossrefGoogle Scholar
  • 14 Foreman JH, Grubb TL, Inoue OJ, Banner SE, Ball KT. Efficacy of single-dose intravenous phenylbutazone and flunixin meglumine before, during and after exercise in an experimental reversible model of foot lameness in horses. Equine Vet J 2010; 42 (38) 601-605
    CrossrefGoogle Scholar
  • 15 Foreman JH, Ruemmler R. Phenylbutazone and flunixin meglumine used singly or in combination in experimental lameness in horses. Equine Vet J 2011; 43 (40) 12-17
    CrossrefGoogle Scholar
  • 16 Gilsenan WF, Getman LM, Parente EJ, Johnson AL. Headshaking in 5 horses after paranasal sinus surgery. Vet Surg 2014; 43 (6) 678-684
    Google Scholar
  • 17 Guedes AG, Matthews NS, Hood DM. Effect of ketamine hydrochloride on the analgesic effects of tramadol hydrochloride in horses with signs of chronic laminitis-associated pain. Am J Vet Res 2012; 73 (5) 610-619
    CrossrefGoogle Scholar
  • 18 Homedes J, Sabaté D, Mayos I. General and gastrointestinal tolerance of suxibuzone, orally administered to horses, compared to phenylbutazone. J Vet Pharmacol Ther 1997; 20 (Suppl) 163-164
    CrossrefGoogle Scholar
  • 19 Hu HH, MacAllister CG, Payton ME, Erkert RS. Evaluation of the analgesic effects of phenylbutazone administered at a high or low dosage in horses with chronic lameness. J Am Vet Med Assoc 2005; 226 (3) 414-417
    CrossrefGoogle Scholar
  • 20 Iburg KC. Der Einfluss von Romifidin, Ketamin und Lidocain auf den thermischen nozizeptiven Schwellenwert beim Pferd. Dissertation. TiHo Hannover; 2013
    Google Scholar
  • 21 Jones E, Viñuela-Fernandez I, Eager RA, Delaney A, Anderson H, Patel A, Robertson DC, Allchorne A, Sirinathsinghji EC, Milne EM, MacIntyre N, Shaw DJ, Waran NK, Mayhew J, Fleetwood-Walker SM. Neuropathic changes in equine laminitis pain. Pain 2007; 132 (3) 321-331
    CrossrefGoogle Scholar
  • 22 Kalpravidh M, Lumb WV, Wright M, Heath RB. Effects of butorphanol, flunixin, levorphanol, morphine, and xylazine in ponies. Am J Vet Res 1984; 45 (2) 217-223
    Google Scholar
  • 23 Love EJ, Taylor PM, Murrell J, Whay HR. Effects of acepromazine, butorphanol and buprenorphine on thermal and mechanical nociceptive thresholds in horses. Equine Vet J 2012; 44 (2) 221-225
    CrossrefGoogle Scholar
  • 24 Malone E, Ensink J, Turner T, Wilson J, Andrews F, Keegan K, Lumsden J. Intravenous continuous infusion of lidocaine for treatment of equine ileus. Vet Surg 2006; 35 (1) 60-66
    CrossrefGoogle Scholar
  • 25 Mills PC, Cross SE. Regional differences in transdermal penetration of fentanyl through equine skin. Res Vet Sci 2007; 82 (2) 252-256
    CrossrefGoogle Scholar
  • 26 Muir WW, Robertson JT. Visceral analgesia: effects of xylazine, butorphanol, meperidine, and pentazocine in horses. Am J Vet Res 1985; 46 (10) 2081-2084
    Google Scholar
  • 27 Naylor RJ, Taylor AH, Knowles EJ, Wilford S, Linnenkohl W, Mair TS, Johns IC. Comparison of flunixin meglumine and meloxicam for post operative management of horses with strangulating small intestinal lesions. Equine Vet J 2014; 46 (4) 427-434
    CrossrefGoogle Scholar
  • 28 Orsini JA, Moate PJ, Kuersten K, Soma LR, Boston RC. Pharmacokinetics of fentanyl delivered transdermally in healthy adult horses – variability among horses and its clinical implications. J Vet Pharmacol Ther 2006; 29 (6) 539-546
    CrossrefGoogle Scholar
  • 29 Poller C, Hopster K, Rohn K, Kästner SB. Nociceptive thermal threshold testing in horses – effect of neuroleptic sedation and neuroleptanalgesia at different stimulation sites. BMC Vet Res 2013; 9 (1) 135
    CrossrefGoogle Scholar
  • 30 Pozzi A, Muir WW, Traverso F. Prevention of central sensitization and pain by N-methyl-D-aspartate receptor antagonists. J Am Vet Med Assoc 2006; 228 (1) 53-60
    CrossrefGoogle Scholar
  • 31 Readford PK, Lester GD, Secombe CJ. Temporohyoid osteoarthropathy in two young horses. Aust Vet J 2013; 91 (5) 209-212
    CrossrefGoogle Scholar
  • 32 Robertson SA, Sanchez LC, Merritt AM, Doherty TJ. Effect of systemic lidocaine on visceral and somatic nociception in conscious horses. Equine Vet J 2005; 37 (2) 122-127
    Google Scholar
  • 33 Robertson SA, Sanchez LC. Treatment of visceral pain in horses. Vet Clin North Am Equine Pract 2010; 26 (3) 603-617
    CrossrefGoogle Scholar
  • 34 Rohrbach H, Korpivaara T, Schatzmann U, Spadavecchia C. Comparison of the effects of the alpha-2 agonists detomidine, romifidine and xylazine on nociceptive withdrawal reflex and temporal summation in horses. Vet Anaesth Analg 2009; 36 (4) 384-395
    CrossrefGoogle Scholar
  • 35 Sabaté D, Homedes J, Salichs M, Sust M, Monreal L. Multicentre, controlled, randomised and blinded field study comparing efficacy of suxibuzone and phenylbutazone in lame horses. Equine Vet J 2009; 41 (7) 700-705
    CrossrefGoogle Scholar
  • 36 Sanchez LC, Robertson SA, Maxwell LK, Zientek K, Cole C. Effect of fentanyl on visceral and somatic nociception in conscious horses. J Vet Intern Med 2007; 21: 1067-1075
    CrossrefGoogle Scholar
  • 37 Schatzman U, Armbruster S, Stucki F, Busato A, Kohler I. Analgesic effect of butorphanol and levomethadone in detomidine sedated horses. J Vet Med A Physiol Pathol Clin Med 2001; 48 (6) 337-342
    CrossrefGoogle Scholar
  • 38 Sellon DC, Monroe VL, Roberts MC, Papich MG. Pharmacokinetics and adverse effects of butorphanol administered by single intravenous injection or continuous intravenous infusion in horses. Am J Vet Res 2001; 62 (2) 183-189
    CrossrefGoogle Scholar
  • 39 Sellon DC, Roberts MC, Blikslager AT, Ulibarri C, Papich MG. Effects of continuous rate intravenous infusion of butorphanol on physiologic and outcome variables in horses after celiotomy. J Vet Intern Med 2004; 18 (4) 555-563
    CrossrefGoogle Scholar
  • 40 Shilo Y, Britzi M, Eytan B, Lifschitz T, Soback S, Steinman A. Pharmacokinetics of tramadol in horses after intravenous, intramuscular and oral administration. J Vet Pharmacol Ther 2008; 31 (1) 60-65
    Google Scholar
  • 41 Stone LS, MacMillan LB, Kitto KF, Limbird LE, Wilcox GL. The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy. J Neurosci 1997; 17 (18) 7157-7165
    Google Scholar
  • 42 Terry RL, McDonnell SM, Van Eps AW, Soma LR, Liu Y, Uboh CE, Moate PJ, Driessen B. Pharmacokinetic profile and behavioral effects of gabapentin in the horse. J Vet Pharmacol Ther 2010; 33 (5) 485-494
    CrossrefGoogle Scholar
  • 43 Van der Werf KA, Davis EG, Kukanich B. Pharmacokinetics and adverse effects of oral meloxicam tablets in healthy adult horses. J Vet Pharmacol Ther 2013; 36 (4) 376-381
    CrossrefGoogle Scholar
  • 44 Zimmerman M. Physiological mechanisms of pain and its treatment. Klinische Anaesthesiologie und Intensivtherapie 1986; S32: 1-19
    Google Scholar